Low-molecular-weight heparins utilization in pregnant and postpartum women: a real-world analysis in China (2016-2021).

ABSTRACT:

Objectives

This study aimed to examine trends in low-molecular-weight heparin (LMWH) use for managing pregnancy-associated venous thromboembolism (VTE) and to explore the correlation between pregnancy-related VTE risk factors and LMWH prescription rates.

Methods

This was a cross-sectional study that analyzed prescription data from pregnant and postpartum women using LMWH to manage VTE, collected during 2016-2021. Risk factors associated with VTE were analyzed. Separately comparing the number of prescriptions, prescription cost, defined daily doses (DDDs), and defined daily cost (DDC) of seven LMWH.

Results

This study included 41,885 prescriptions, with the average age of patients being 32 ± 4.69 years old. The most common risk factors for VTE during pregnancy and the

SUBMITTER: Liu HR 

PROVIDER: S-EPMC11973347 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature